Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Pszczyna

4 clinical trials in Pszczyna, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Pszczyna at a glance
4
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

4 trials in Pszczyna

Open in trial search
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Clazakizumab
  • Sponsor:CSL Behring LLC
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Darbepoetin Alfa
  • Sponsor:Genexine Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Darbepoetin Alfa
  • Sponsor:Genexine Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Upacicalcet Sodium Hydrate
  • Sponsor:Pathalys Pharma Inc.

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Pszczyna

What the registry says about research in the country

01 Kidney Disease Research

Innovative clinical trials focusing on secondary hyperparathyroidism (SHPT) in patients undergoing hemodialysis, evaluating new therapeutic approaches for better disease management.

  • End-stage kidney disease (ESKD)
  • Hemodialysis treatments
  • Hormone regulation therapy

Studies aim to assess novel treatments for maintaining optimal hormone levels in dialysis patients.

02 Anemia Management

Research comparing different treatments for anemia in chronic kidney disease, specifically evaluating the effectiveness of various erythropoiesis-stimulating agents.

  • Hemoglobin level control
  • Dialysis-related anemia
  • Comparative treatment efficacy

Trials focus on optimizing anemia management strategies for dialysis patients.

03 Cardiovascular Health

Studies investigating treatments for atherosclerotic cardiovascular disease in ESKD patients, with emphasis on reducing inflammatory markers.

  • Cardiovascular outcomes
  • Inflammation markers
  • Dialysis complications

Research aims to improve cardiovascular outcomes in the dialysis patient population.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.